Scientific publications

• I.M.Gudz Special role of cilostazol on the treatment of patients with manifestation of claudication intermittent acording to the recommendations evidence-based medicine

• I.I. Kobza, T.B. Rudyk, T.I. Kobza Modern antiplatelet therapy in patients with cardiovascular diseases

• V. Subbotin Сomplex correction of platelet aggregation activity as the prevention of critical ischemia progression in patients with diabetic foot

• Gudz I.M. Clinical management of patients with

• Olena Voloshyna Modern recommendations on diagnostics and treatment of lower extremity arteries diseases in the family doctors practice (review of the literature)

• Cilostazol – antiplatelet drug with great prospects

• Secondary stroke prevention: what do we know about cilostazol?

• Cilostazol: many years of experience and new research

• V.A. Prasol, K.V. Miasoiedov, V.V. Shaprynskyi, ADVISABILITY OF USING CILOSTAZOL IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA

• Mohammed A. Abosheasha, Afnan H. El-Gowily, Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach

• Conservative therapy of diseases of the peripheral arteries of the lower extremities European Society of Vascular Surgery (ESVS) 2024 (ZU)